Abstract
The development of a transmission-blocking vaccine (TBV) against malaria is hampered by poor understanding of functional antibody responses. In this issue of Immunity, Fabra-Garcia et al., Ivanochko et al., and Tang et al. isolate human monoclonal antibodies against the two most promising TBV candidates, Pfs48/45 and Pfs230, and map the epitopes responsible for potent transmission-reducing activity.
Original language | English (US) |
---|---|
Pages (from-to) | 234-236 |
Number of pages | 3 |
Journal | Immunity |
Volume | 56 |
Issue number | 2 |
DOIs |
|
State | Published - Feb 14 2023 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Infectious Diseases